Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes.

• Status: Terminated
• Trial end date: 2018-04-20
• Target enrollment: 0
• Participant gender: Female

Summary

The main objective of this trial is to study the occurrence of preeclampsia in recipients of donated oocytes receiving aspirin at an early stage during pregnancy and to compare the results with those obtained in patients receiving placebo.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Instituto de Investigacion Sanitaria La Fe
• Treatments: Aspirin

Criteria

Inclusion Criteria:

• Patients over 18 years.

• Recipients of donated oocytes.

• Pregnant women.

• Single or twin gestations.

• Patients who accept the conditions of the study by signing the appropriate informed consent.

Exclusion Criteria:

• Known allergy to acetylsalicylic acid .

• Personal history of peptic ulcer.

• Triplets.

• Use of prostaglandin inhibitors within 10 days prior to baseline.

• Personal history of chronic kidney, thyroid, liver or heart disease.

• Psychiatric or cognitive pathology that prevents understanding of the conditions of informed consent.